AVITA Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	10.24	14.05	22.12	18.16	110.75
Short-Term Investments	7.94	21.84	66.94	61.18	-
Cash & Short-Term Investments	18.19	35.89	89.06	79.34	110.75
Cash Growth	-49.32%	-59.71%	12.24%	-28.36%	50.39%
Accounts Receivable	9.09	11.79	7.66	3.52	3.47
Other Receivables	-	-	0.03	0.9	3.94
Total Trade Receivables	9.09	11.79	7.69	4.41	7.4
Inventory	6.93	7.27	5.6	2.13	1.65
Other Current Assets	1.29	2.06	1.66	1.58	1.33
Total Current Assets	35.49	57	104.01	87.46	121.33
Net Property, Plant & Equipment	11.53	13.59	4.32	2.05	2.94
Other Intangible Assets	5.65	5.57	0.49	0.47	0.47
Long-Term Investments	-	-	-	6.93	-
Other Long-Term Assets	3.73	3.55	2.83	1.36	0.96
Total Assets	56.39	79.71	111.64	98.26	125.5
Accounts Payable	8.96	6.29	3.79	3	3.12
Accrued Expenses	7.81	10.45	7.97	6.62	3.32
Short-Term Debt	42.98	-	-	-	-
Unearned Revenue	0.29	0.32	0.36	0.7	1.08
Other Current Liabilities	2.92	3.41	1.43	1.07	0.95
Total Current Liabilities	62.68	20.16	13.2	10.69	7.39
Long-Term Debt	-	42.25	39.81	-	-
Long-Term Leases	2.14	2.84	1.7	0.31	0.88
Other Long-Term Liabilities	7.94	9.4	6.82	1.27	0.5
Total Long-Term Liabilities	10.08	54.49	48.34	1.58	1.38
Total Liabilities	73.04	74.97	61.89	12.97	9.85
Common Stock	0	0	0	0	0
Treasury Stock	-1.29	-1.32	-1.13	-0.13	-
Additional Paid-in Capital	394.41	367.57	350.04	339.83	328.89
Accumulated Other Comprehensive Income	-1.37	-1.94	-1.89	7.63	8.26
Retained Earnings	-408.4	-359.81	-297.97	-262.59	-221.5
Total Common Shareholders' Equity	-16.65	4.5	49.06	84.74	115.66
Minority Interest	-	0.24	0.69	0.56	-
Shareholders' Equity	-16.65	4.74	49.75	85.3	115.66
Total Liabilities & Equity	56.39	79.71	111.64	98.26	125.5
Total Debt	45.12	45.09	41.51	0.31	0.88
Net Cash (Debt)	-26.93	-9.2	47.54	79.04	109.87
Net Cash Growth	-	-	-39.85%	-28.06%	53.19%
Net Cash Per Share	-19.34	-7.11	37.54	63.23	96.91
Book Value	-16.65	4.5	49.06	84.74	115.66
Book Value Per Share	-11.95	3.48	38.73	67.79	102.01
Tangible Book Value	-22.3	-1.07	48.57	84.28	115.18
Tangible Book Value Per Share	-16.00	-0.83	38.35	67.42	101.60

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q